What is Impella?

Introduction

Impella is a small heart pump that provides temporary circulatory support for patients with severe heart failure or cardiogenic shock. It helps maintain blood flow when the heart is too weak to pump effectively on its own.

How Does the Impella Device Work?

The Impella device is inserted into the heart through a catheter, usually via the femoral artery in the leg or through an alternative access site. Once inside the heart, it assists in pumping blood from the left ventricle into the aorta, ensuring that vital organs receive adequate oxygen and nutrients.

Key Functions:

  • Supports circulation in cases of acute heart failure or cardiogenic shock.
  • Reduces the workload on the heart, allowing it to recover.
  • Can be used during high-risk percutaneous coronary interventions (PCI) to stabilize the patient.

Who Needs an Impella Device?

Impella is commonly used in patients with: - Cardiogenic shock after a heart attack. - Severe left ventricular failure. - High-risk PCI (such as coronary artery stenting in patients with poor cardiac function). - Post-cardiotomy shock (heart failure following heart surgery).

Risks and Considerations

While the Impella device provides significant benefits, it is associated with potential risks, including: - Bleeding or vascular complications at the insertion site. - Hemolysis (destruction of red blood cells). - Arrhythmias. - Infection.

Conclusion

The Impella device is a life-saving innovation in interventional cardiology, providing crucial circulatory support to critically ill patients. However, it should only be used in carefully selected cases under expert medical supervision.

Source recommendations

1. American College of Cardiology Guidelines on Mechanical Circulatory Support

  1. https://www.acc.org/Clinical-Topics/Heart-Failure-and-Cardiomyopathies/Mechanical-Circulatory-Support
  2. https://pubmed.ncbi.nlm.nih.gov/25861963/
  3. https://www.acc.org/latest-in-cardiology/articles/2016/08/31/08/01/use-of-acute-mechanical-circulatory-support-devices
  4. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000507
  5. https://scai.org/publications/clinical-documents/scaiacchfsasts-clinical-expert-consensus-statement-use-percutaneous

2. European Society of Cardiology Guidelines on Acute and Chronic Heart Failure

  1. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Acute-and-Chronic-Heart-Failure
  2. https://pubmed.ncbi.nlm.nih.gov/34447992/
  3. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Focused-Update-on-Heart-Failure-Guidelines
  4. https://academic.oup.com/eurheartj/article/42/36/3599/6358045
  5. https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.2333

Our advantages:

patient2376100
Best practices from USA, EU and Japan
Our answers to your questions are based on the clinical recommendations of countries with the most developed healthcare systems in the field of cardiology in the USA, the EU and Japan.
prescription18648039
Always up-to-date information
On a daily basis, we monitor for you all new scientific research publications in leading scientific journals on medical issues of interest to you.
We monitor all innovations and changes in the field of cardiac disease treatment on a daily basis.
fvfflf7q
Get second opinion
Here you can learn everything that even your doctor may not know about cardiology (if he does not speak English and he does not read 117 leading medical journals on cardiology every month).
1xr4duup
The most comprehensive and up-to-date collection of free cardiology materials
Our website contains the most comprehensive and up-to-date collection of free cardiology materials in your country.
Every 3-5 years, half of the scientific approaches to treatment in the field of cardiology are reviewed as a result of specialized scientific discoveries. With us, you don't have to wait these years to learn about the best ways to treat you and your loved ones.
arrow
Please register in order to receive information regarding possible complications and new approaches to treatment of cardiovascular diseases via email in our Newsletters.
arrow